Position in NTRA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$16,558
+$13,822 QoQ
Shares Held
61
+258.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#728
of 834 holders
Holding Since
Dec 2023
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Johnson Financial Group, Inc. holds $1,960,047 across 8 Diagnostics & Research names. NTRA ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
1,437 | $756,494 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,487 | $745,522 | |
| 3 | DHR |
Danaher Corp /De/
|
1,742 | $331,816 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
304 | $58,738 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
51 | $27,009 | |
| 6 | DGX |
Quest Diagnostics Inc
|
89 | $18,863 | |
| 7 | NTRA |
Natera, Inc.
This page
|
61 | $16,558 | |
| 8 | A |
Agilent Technologies, Inc.
|
38 | $5,047 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,558 | 61 | Shares | Defined | 2026-08-10 | |
| 2025-09-30 | $2,736 | 17 | Shares | Defined | 2025-11-13 | |
| 2024-03-31 | $274 | 3 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $187 | 3 | Shares | Defined | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||